Effentora® in Clinical Practice - a Non-interventional Study to Evaluate Satisfaction and Tolerability (ERKENTNIS)

Cephalon

Status: Completed

Conditions: Cancer; Pain

Treatments: Drug: Effentora®

Study type: Observational

Funder types: Industry

Identifiers

NCT01400854

C25608/5008

Details and patient eligibility

About

Aim of this non-interventional study is to investigate the tolerability of Effentora® in cancer pain patients with breakthrough pain under real-life conditions in clinical practice.

Full description

In addition to the effectiveness of Effentora® therapy, safety, general feasibility and the impact of therapy on the patients' quality of life are of interest.

Enrollment: 600 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• decision to start treatment with Effentora
• prescription in accordance with Summary of Product Characteristics (SmPC)
• personally signed and dated Informed Consent document

Exclusion criteria

• any subject considered unsuitable according to SmPC

Trial design

600 participants in 1 patient group

Effentora®

Description:

Single group prospective treatment cohort

Treatment:

Drug: Effentora®